Standout Papers

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a r... 2015 2026 2018 2022 307
  1. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial (2015)
    Kenneth R. Chapman, Jonathan Burdon et al. The Lancet

Immediate Impact

2 by Nobel laureates 1 from Science/Nature 53 standout
Sub-graph 1 of 22

Citing Papers

Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
2025 Standout
Atopic dermatitis
2025 Standout
1 intermediate paper

Works of Zhenling Yao being referenced

Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study
2021
The first‐in‐human study of CNTO 7160, an anti‐interleukin‐33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis
2020

Author Peers

Author Last Decade Papers Cites
Zhenling Yao 327 232 464 27 1.1k
Mohammad Tabrizi 454 387 550 26 1.3k
Julia Calzada‐Wack 116 220 659 40 1.2k
Antje Lebrecht 180 204 396 56 1.3k
Subhrajit Saha 315 159 487 36 1.0k
Yong Meng 205 89 477 36 958
Wim H.A. Dokter 361 249 466 44 1.3k
CS Potten 283 97 451 15 1.3k
Santosh Kumar 194 95 524 42 1.2k
Andrea Balogh 255 225 761 36 1.3k
Randolph Hutter 97 320 374 31 1.1k

All Works

Loading papers...

Rankless by CCL
2026